Example: Heart Attack

Clinical Trials on Alopecia Areata

Total 334 results

NCT02599129

Terminated

A Study of Secukinumab for the Treatment of Alopecia Areata

Conditions: Alopecia Areata
NCT04680234

Completed

Superficial Cryotherapy Versus Microneedling in Alopecia Areata

Conditions: Alopecia Areata
NCT03535233

Completed

Topical 5% Minoxidil and Potent Topical Corticosteroid Versus Intralesional Corticosteroid in the Treatment of Alopecia Areata

Conditions: Alopecia Areata
NCT02684123

Unknown status

Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata

Conditions: Alopecia Areata
NCT02691117

Terminated

Topical Garlic Concentrate for Alopecia Areata in Children

Conditions: Alopecia Areata
NCT02299297

Completed

Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis

Conditions: Alopecia Areata
NCT04797650

Not yet recruiting

A Phase 3 Study to Evaluate the Efficacy and Safety of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata (THRIVE-AA2)

Conditions: Alopecia Areata
NCT04518995

Recruiting

A Phase 3 Study to Evaluate the Efficacy and Safety of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata (THRIVE-AA1)

Conditions: Alopecia Areata
NCT03847441

Completed

Topical Calcipotriol Versus Narrowband Ultraviolet B in Treatment of Alopecia Areata

Conditions: Alopecia Areata
NCT03800979

Completed

Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata

Conditions: Alopecia Areata
NCT02684097

Completed

A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata

Conditions: Alopecia Areata
NCT01736007

Withdrawn

Childhood Alopecia Areata Study Using the 308-nm Excimer Laser

Conditions: Alopecia Areata
NCT01950780

Completed

Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata

Conditions: Alopecia Areata
NCT04556734

Recruiting

Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata

Conditions: Alopecia Areata
NCT01917058

Withdrawn

A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia Areata

Conditions: Alopecia Areata
NCT02018042

Completed

An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata

Conditions: Alopecia Areata
NCT04006457

Recruiting

Long-Term PF-06651600 for the Treatment of Alopecia Areata

Conditions: Alopecia Areata
NCT04517864

Recruiting

PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA

Conditions: Alopecia Areata
NCT01802177

Unknown status

Excimer Light for Alopecia Areata

Conditions: Alopecia Areata
NCT04412148

Recruiting

Modified SALT Score for Alopecia Areata

Conditions: Alopecia Areata
NCT04660786

Not yet recruiting

Intralesional Vitamin D in Alopecia Areata

Conditions: Alopecia Areata
NCT04228029

Active, not recruiting

Comparative Study for Treatment of Alopecia Areata Using Carboxytherapy and Intralesional Steroids

Conditions: Alopecia Areata
NCT03732807

Active, not recruiting

PF-06651600 for the Treatment of Alopecia Areata

Conditions: Alopecia Areata
NCT04147845

Completed

Transepidermal Delivery of Triamcinolone Acetonide or Platelet Rich Plasma Using Either Fractional Carbon Dioxide Laser or Microneedling in Treatment of Alopecia Areata

Conditions: Alopecia Areata
NCT04793945

Not yet recruiting

Excimer Light and Topical Steroid in Treatment of Alopecia Areata

Conditions: Alopecia Areata